Back to search

Article

Impact of Omicron variant on the response to SARS-CoV-2 mRNA Vaccination in multiple myeloma

2022-02-26

Abstract excerpt

Multiple myeloma (MM) patients may have a reduced response to vaccination due to immunodeficiency. The humoral and cellular response to SARS-CoV-2 mRNA full vaccination and booster dose as well as the impact of spike variants, including the emerging Omicron one, are still unclear and have been investigated in this study in a cohort of MM patients and those with pre-malignant monoclonal gammopathies. Firstly, we ha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
74540686-8a36-5936-ad49-4559c89b839d
DOI
10.1101/2022.02.25.22271501
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of Omicron variant on the response to SARS-CoV-2 mRNA Vaccination in multiple myelomaDOI 10.1101/2022.02.25.22271501
Cellular Mechanisms Associated with Sub-Optimal Immune Responses to SARS-CoV-2 Bivalent Booster Vaccination in Patients with Multiple MyelomaSemantic proximity
Loss of Anti-Spike Antibodies Following mRNA Vaccination for COVID-19 Among Patients with Multiple MyelomaSemantic proximity
Omicron Reactive Multi Protein Specific CD4 T Cells Defines Cellular Immune Response Induced by Inactivated Virus VaccinesSemantic proximity
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico InvestigationSemantic proximity
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response in multiple myeloma patientsSemantic proximity
Fatal breakthrough infection after anti-BCMA CAR-T therapy highlights suboptimal immune response to SARS-CoV-2 vaccination in myeloma patientsSemantic proximity
Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies.Semantic proximity
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myelomaSemantic proximity
SARS-CoV-2 Vaccines in Patients With Multiple MyelomaSemantic proximity
Select a neighboring publication to make it the new centre.